Who We Are
ImmunoGen is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology. ImmunoGen’s lead product candidate, mirvetuximab soravtansine, is being advanced to a Phase 3 trial for FRα-positive platinum-resistant ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease. ImmunoGen’s ADC technology is used in Roche's marketed product, Kadcyla, in three other clinical-stage ImmunoGen product candidates, and in programs in development by partners Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda. More information about ImmunoGen can be found at www.immunogen.com.
ImmunoGen Inc. is seeking a highly motivated and detail oriented individual for a Quality Assurance Specialist I position. The position will work in close collaboration with the Non-clinical, Clinical, Regulatory and Pharmacovigilance departments to ensure compliance with Good Clinical Practice(s), Good Pharmacovigilance Practices (GVPs) and Good Clinical Laboratory Practices (GCLPs),. In this position, you will be responsible for supporting the Immunogen Quality system, including company oversight of vendors/CROs/clinical sites.
The Quality Assurance Specialist I will:
Who You Are
BS/BA in field of science such as chemistry, microbiology, biology and biochemistry or BS in a related science field. One to two years post-graduate experience in science, quality or clinical research strongly preferred.
ImmunoGen, Inc. is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.
ImmunoGen, Inc. does not accept non-solicited resumes or candidate submittals from search/recruiting agencies not already on ImmunoGen, Inc.’s approved agency list. Unsolicited resumes or candidate information submitted to ImmunoGen, Inc. by search/recruiting agencies not already on ImmunoGen, Inc. approved agency list shall become the property of ImmunoGen, Inc. and if the candidate is subsequently hired by ImmunoGen, Inc., ImmunoGen, Inc. shall not owe any fee to the submitting agency.